Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)

ClinicalTrials.gov ID: NCT01688947

Public ClinicalTrials.gov record NCT01688947. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 7:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the analgesic efficacy of 2 dose levels of V116517 versus placebo.

Study identification

NCT ID
NCT01688947
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
105 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2012
Primary completion
Feb 28, 2014
Completion
Mar 31, 2014
Last update posted
May 11, 2014

2012 – 2014

United States locations

U.S. sites
28
U.S. states
13
U.S. cities
28
Facility City State ZIP Site status
Investigational Site Tucson Arizona 85704
Investigational Site La Jolla California 92037-7651
Investigational Site North Hollywood California 91606
Investigational Site Boca Raton Florida 33486
Investigational Site Bradenton Florida 34205
Investigational Site DeLand Florida 32720
Investigational Site Fort Myers Florida 33916
Investigational Site Lynn Haven Florida 32444
Investigational Site North Miami Florida 33161
Investigational Site Orlando Florida 32806
Investigational Site Oviedo Florida 32765
Investigational Site Palm Beach Gardens Florida 33410
Investigational Site Sarasota Florida 34233
Investigational Site St. Petersburg Florida 33716
Investigational Site Sunrise Florida 33351
Investigational Site Decatur Georgia 30033
Investigational Site Chicago Illinois 60634
Investigational Site Prairie Village Kansas 66206
Investigational Site New Bedford Massachusetts 02740
Investigational Site Bay City Michigan 48706
Investigational Site Bingham Farms Michigan 48025
Investigational Site Pinconning Michigan 48650
Investigational Site Las Vegas Nevada 89123
Investigational Site Albuquerque New Mexico 87108
Investigational Site Charlotte North Carolina 28204
Investigational Site Raleigh North Carolina 27609
Investigational Site Austin Texas 78731
Investigational Site Salt Lake City Utah 84106

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01688947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2014 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01688947 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →